Growth Science
Growth Science Ventures (GS Ventures) is a privately held venture capital firm deploying equity capital into early-stage companies in complex industries where systemic bottlenecks constrain value, using proprietary dynamic value chain analysis developed over 18 years.
- Company typePrivate
- Founded2006
- HeadquartersLake Oswego, United States
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Growth Science does
Growth Science International, LLC (operating as Growth Science Ventures or GS Ventures) is a privately held venture capital firm founded in 2006 and headquartered in Lake Oswego, Oregon. The firm deploys equity capital into early-stage companies operating in complex industries where systemic bottlenecks constrain value creation. Its central offering is not a software product but a proprietary analytical infrastructure—developed over approximately 18 years—that dynamically tracks value chain behavior to identify where constraints accumulate and where capital can produce system-level unlocks. The methodology originated from a collaboration with Clayton Christensen and Intel, and the firm operationalizes it through a three-step protocol: deconstruct the system, identify the bottlenecks, and deploy capital to clear them.\n\nGrowth Science Ventures invests directly into portfolio companies, frequently co-investing with strategic partners—most notably Corteva Catalyst, the investment arm of Corteva Inc. Active portfolio verticals include agritech (Resurrect Bio, IBI Ag, Micropep, Solasta Bio, Puna Bio), diagnostics and health (Viome, Hone Health, Tasso, Firefly Neuroscience, Getlabs), and multi-industry companies (Pyrra Technologies, Golden). The firm cites 60+ research collaborations and analysis of 1,000+ market segments as the empirical foundation underlying its investment approach. Revenue is generated from investment returns—capital gains realized through exits, acquisitions, and public offerings such as Firefly Neuroscience's NASDAQ debut—rather than disclosed management fees or carried interest.\n\nThe firm operates with a small team of 1-10 employees and a global deployment footprint spanning the United States, France, India, and the United Kingdom. With no discrete SaaS products, APIs, or commercial software offerings, the firm monetizes through transaction-based investment outcomes rather than recurring contracts. Leadership comprises CEO Zeke Camusio and Founder Thomas Thurston. Ownership is privately held at the Growth Science International, LLC level with no disclosed parent company, institutional investors, or fund-size transparency; this lack of disclosure limits external visibility into capital base and revenue mechanics.
Growth Science firmographics
Firmographics- Name
- Growth Science
- Legal name
- Growth Science International, LLC
- Website
- https://growthsci.com
- Company type
- Private
- Founded year
- 2006
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Growth Science Ventures (GS Ventures) is a privately held venture capital firm deploying equity capital into early-stage companies in complex industries where systemic bottlenecks constrain value, using proprietary dynamic value chain analysis developed over 18 years.
- Ownership category
- akta.pro rank
Growth Science industry classification
Industry- Product category
- Venture Capital
- NAICS
- Portfolio Management and Investment Advice (52394)
- SIC
- Investment Advice (6282)
- akta.pro primary industry
- Agriculture & Food / AgTech Growth Equity (FSANACAM)
- akta.pro secondary industry
- Healthcare & Life Sciences Growth Equity (FSANACAB)
Keywords
Where Growth Science is headquartered
LocationHeadquarters
- HQ city
- Lake Oswego
- HQ country
- United States
- HQ region
- North America
Markets served
Growth Science business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales
Revenue model
- Investment Returns / Capital Gains: Growth Science Ventures generates returns through equity investments in portfolio companies. The firm identifies constrained systems and deploys capital to unlock value, earning returns through exits, acquisitions, and public offerings of portfolio companies.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels2 records
Growth Science product offering
Product offeringCore offering
Growth Science is a venture capital firm that helps executives risk-manage organic innovation, M&A, and venture capital portfolios. The firm identifies bottlenecks in complex industries and deploys capital through equity investments to resolve them, operating a proprietary analytical framework originated in 2006 from a collaboration with Clayton Christensen and Intel. Capital is deployed into agritech, diagnostics, and multi-industry companies, frequently as co-investments alongside strategic partners such as Corteva Catalyst.
Product overview
Growth Science (also known as Growth Science Ventures or GS Ventures) is a venture capital firm, not a traditional software product company. Its core offering is analytical infrastructure and investment methodology — a systematic approach to finding bottlenecks in complex industries where value accumulates or gets stuck, then deploying capital to resolve those constraints. The firm has spent nearly 18 years building and pressure-testing its analytical methodology through 60+ research collaborations and 1,000+ market segment analyses. There are no discrete software products, SaaS offerings, or modules to enumerate; the company provides investment services and strategic capital deployment across industries including agritech, diagnostics, and multi-industry sectors.
Differentiator
Problem solved
Functional benefit
Products and services
- Growth Science Venture Capital Investments Equity capital deployment into agritech, diagnostics, and multi-industry companies that address structural bottlenecks in complex industries, typically executed as direct investments or co-investments alongside strategic partners such as Corteva Catalyst.
- Executive Innovation and M&A Risk Management Advisory Advisory engagement that helps corporate executives apply the Growth Science framework to risk-manage their organic innovation pipelines, M&A programs, and venture capital portfolios.
Companies that use Growth Science
Customer profileSegments3 records
Ideal customer profiles2 records
Growth Science technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
Growth Science partnerships and signals
Strategic signalScale indicators3 records
Recent moves6 records
Expansion highlights4 records
Growth Science competitors and assessment
Company assessmentBroad incumbents
- Flagship Pioneering: Large life-sciences VC that originates and builds companies around breakthrough scientific platforms. Comparable in its deep-R&D-driven investment thesis and healthcare/diagnostics focus, though at significantly larger scale.
- ARCH Venture Partners: Long-tenured deep-tech and life-sciences VC that funds companies built on complex scientific breakthroughs. Similar in its patience for long-horizon, science-heavy bets including diagnostics and biotech.
- Leaps by Bayer: Bayer's impact-driven investment vehicle backing breakthroughs in health and agriculture. Mirrors the Growth Science-Corteva Catalyst dynamic of a corporate parent co-investing with an independent VC partner.
- Khosla Ventures: Large, science-heavy venture firm investing across technology, sustainability, health, and food/ag. Comparable in its willingness to invest in contrarian, science-based, bottleneck-solving companies at early stages.
- Breakthrough Energy Ventures: Patient, science-led venture fund backed by ultra-high-net-worth investors, focused on climate, agriculture, and sustainability. Comparable in its tolerance for long-horizon, science-intensive bets and concentration in sustainability-adjacent verticals.
Direct peers
- Finistere Ventures: Agritech- and food-tech-focused venture firm investing in crop science, biologicals, and digital agriculture. Direct vertical overlap with Growth Science's agritech portfolio (seed treatments, bio-pesticides).
- Obvious Ventures: Mission-driven VC investing in companies addressing systemic 'world-positive' problems across health, food, and sustainability. Comparable in its thesis-driven approach to identifying high-impact investment opportunities in complex systems.
- DCVC: Deep-tech VC that backs companies applying breakthroughs in materials, biology, and computing to large, hard problems. Comparable investment philosophy of funding bottleneck-resolving science-based companies.
- S2G Ventures: Venture firm focused on food, agriculture, and ocean technology, with strategic corporate LPs. Closely comparable to Growth Science's agritech focus and Corteva-style corporate co-investor model.
- Lux Capital: Science- and technology-focused venture firm that invests in 'counter-conventional' companies tackling hard scientific and engineering bottlenecks. Most comparable to Growth Science's thesis of finding and funding companies that resolve system-level constraints.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights5 records
Customer concentration
Growth Science social profiles
Digital presenceGrowth Science financial estimates
Financial estimateRevenue estimate
Valuation estimate
Growth Science leadership team
Management profileNumber of profiles
Profiles1 record
Growth Science funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Growth Science M&A and investment
M&A and investmentM&A
Investments1 record
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Growth Science
What does Growth Science do?
Growth Science is a venture capital firm that helps executives risk-manage organic innovation, M&A, and venture capital portfolios. The firm identifies bottlenecks in complex industries and deploys capital through equity investments to resolve them, operating a proprietary analytical framework originated in 2006 from a collaboration with Clayton Christensen and Intel. Capital is deployed into agritech, diagnostics, and multi-industry companies, frequently as co-investments alongside strategic partners such as Corteva Catalyst.
Is Growth Science a public or private company?
Growth Science is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Growth Science founded?
Growth Science was founded in 2006. It employs 1 to 10 people.
Where is Growth Science based?
Growth Science is headquartered in Lake Oswego, United States, in the North America region.
How does Growth Science make money?
One revenue line is on record: investment Returns / Capital Gains.
Who are Growth Science's main competitors?
Broad incumbents on record are Flagship Pioneering, ARCH Venture Partners, Leaps by Bayer, Khosla Ventures and Breakthrough Energy Ventures. Direct peers are Finistere Ventures, Obvious Ventures, DCVC, S2G Ventures and Lux Capital.
Does Growth Science have an API?
No public API is recorded for Growth Science.
What industry is Growth Science in?
Growth Science's product category is Venture Capital. Its primary akta.pro industry code is FSANACAM, Agriculture & Food / AgTech Growth Equity, with a secondary code of FSANACAB, Healthcare & Life Sciences Growth Equity. Its NAICS code is 52394 and its SIC code is 6282.